The introduction of new (and expensive) pharmaceutical products is one of the major challenges for health systems. The search for new institutional arrangements is natural. The use of the so-called risk-sharing agreements is one example. Recent discussions have somewhat neglected the economic fundam
✦ LIBER ✦
Risk-sharing agreements for innovative drugs
✍ Scribed by Gérard de Pouvourville
- Publisher
- Springer
- Year
- 2006
- Tongue
- French
- Weight
- 528 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1618-7598
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The simple economics of risk-sharing agr
✍
Pedro Pita Barros
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 122 KB
👁 2 views
Risk management: Time for innovative app
✍
Venkateswara R. Rao
📂
Article
📅
1995
🏛
Springer
🌐
English
⚖ 789 KB
What is shared? A framework for understa
✍
Richard E. West
📂
Article
📅
2008
🏛
Springer US
🌐
English
⚖ 256 KB
Analysis of a pharmaceutical risk sharin
✍
Gregory S. Zaric; Bernie J. O'Brien
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 173 KB
👁 1 views
## Abstract Many public and private healthcare payers use formularies as a tool for controlling drug costs and quality. Although the price per dose is often negotiated as part of the formulary listing, payers may still face unlimited financial risk if demand is much greater than expected at the tim
Classification of drugs for teratogenic
✍
G. Alván; B. R. Danielsson; I. Kihlström; P. Lundborg; B. Prame; E. Ridley; R. S
📂
Article
📅
1995
🏛
Springer
🌐
English
⚖ 239 KB
Shared risk, shared reward a profit mode
✍
Rhett Brymer; Nathan Fisher; Ben Wiant
📂
Article
📅
2004
🏛
John Wiley and Sons
⚖ 116 KB